2025-07-24 - Analysis Report
Okay, here's an analysis of Albemarle Corp (ALB), incorporating the data you provided.

## Albemarle Corp (ALB) Analysis

Albemarle Corp is a specialty chemicals company with a focus on lithium, bromine specialties, and catalysts.

### 1. Performance vs. S&P 500 (VOO)

**Key Numbers:**

*   **ALB Cumulative Return:** 38.35%
*   **VOO Cumulative Return:** 97.07%
*   **Absolute Divergence (ALB - VOO):** -68.8%
*   **Divergence Range:** Max 312.9, Min -90.2
*   **Relative Divergence:** 5.3 (Indicates ALB's current divergence is near the bottom of its historical range)

**Analysis:**

ALB has significantly underperformed the S&P 500 over the period considered. The -68.8% absolute divergence highlights this. The Relative Divergence of 5.3 suggests that ALB's current underperformance relative to the S&P 500 is near the bottom of its historical range, potentially indicating a possible future rebound or continued struggle.

**Alpha, Beta Analysis Table:**

| Year       | CAGR   | MDD    | Alpha  | Beta | Cap(B) |
|------------|--------|--------|--------|------|--------|
| 2015-2017  | 99.0%  | 8.1%   | 70.0%  | 0.0  | 14.1   |
| 2016-2018  | 13.0%  | 58.0%  | -5.0%  | 0.0  | 8.5    |
| 2017-2019  | -44.0% | 58.0%  | -74.0% | -0.0 | 8.1    |
| 2018-2020  | 101.0% | 62.9%  | 81.0%  | 0.6  | 16.3   |
| 2019-2021  | 268.0% | 62.9%  | 220.0% | 0.6  | 25.8   |
| 2020-2022  | 239.0% | 75.6%  | 237.0% | 0.8  | 23.9   |
| 2021-2023  | -53.0% | 77.5%  | -71.0% | 0.6  | 15.9   |
| 2022-2024  | -200.0%| 77.5%  | -225.0%| 0.7  | 9.5    |
| 2023-2025  | -310.0%| 77.5%  | -359.0%| 3.0  | 9.2    |

**Analysis of Table:**

*   **CAGR:**  Shows highly variable annual growth, with significant positive periods followed by strong negative periods in more recent years.
*   **MDD (Maximum Drawdown):**  High MDD values indicate substantial risk and volatility, especially in the later periods.
*   **Alpha:** Fluctuates significantly, indicating periods of outperformance (positive alpha) and underperformance (negative alpha) relative to the market.  The recent negative Alpha values are concerning.
*   **Beta:** Generally low, suggesting low correlation to the overall market movement, but increasing to 3.0 in the last period, indicating a much higher sensitivity to market movements.
*   **Cap(B):** Market capitalization changes over time reflecting the stock performance.

### 2. Recent Price Action

**Key Numbers:**

*   **Current Price:** 78.195
*   **Previous Close:** 83.24
*   **Change:** -6.06
*   **5-day Moving Average:** 76.722
*   **20-day Moving Average:** 69.38
*   **60-day Moving Average:** 62.5605

**Analysis:**

The stock price experienced a significant drop of -6.06 from the previous close, indicating a substantial negative market reaction.  The current price is above all moving averages, which could be seen as a short-term positive.  However, the sharp drop warrants caution.

### 3. Indicators and Signals

**Key Numbers:**

*   **MRI (Market Risk Indicator):** 0.3359 (Low Risk)
*   **RSI (Relative Strength Index):** 78.56 (Overbought)
*   **PPO (Percentage Price Oscillator):** 1.4846
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.33)
*   **Delta Relative Divergence (20-day):** 1.9 (Positive - Short-term Increase)
*   **Expected Return:** 2129.1%

**Analysis:**

*   **MRI:** The low MRI suggests that, overall, market risk is low.
*   **RSI:** The high RSI value indicates that the stock is currently overbought and may be due for a correction.
*   **PPO:** The positive PPO suggests that the short-term moving average is above the long-term moving average, indicating upward momentum.
*   **Hybrid Signal:** The signal suggests a cautious approach with a recommendation to allocate 80% of available cash to buying 1 share.
*   **Delta Relative Divergence:** The positive value suggests short-term upward momentum in the stock's performance relative to the S&P 500.
*   **Expected Return:** The extremely high expected return should be viewed with skepticism.  Such high returns are rarely achievable and may be based on overly optimistic assumptions.
*   **Price Change Impact:** The price decrease from previous close of -6.06 indicates potential instability and requires careful observation.

### 4. Recent News & Significant Events

*   **[2025-07-20]:** Major business developments, regulatory changes, or market events affecting Albemarle.
*   **[2025-07-22]:** Analysts' discussions on Albemarle's performance in the context of industry trends and global economic factors.
*   **[2025-07-23]:** Notable stock volatility influenced by recent news, earnings reports, or executive actions.
*   **[2025-07-21]:** Market experts highlighting risks and opportunities, advising investors to monitor news and announcements.

**Analysis:**

The news snippets indicate that Albemarle is experiencing significant events causing volatility and attracting analyst attention.  Investors should closely monitor news releases and company announcements to understand the drivers behind these events.

### 5. Recent Earnings Analysis

| Date       | EPS   | Revenue   |
|------------|-------|-----------|
| 2025-04-30 | 0     | 1.08 B$   |
| 2024-11-06 | -9.45 | 1.35 B$   |
| 2024-07-31 | -1.96 | 1.43 B$   |
| 2024-05-01 | -0.08 | 1.36 B$   |
| 2025-04-30 | -0.08 | 1.36 B$   |

**Analysis:**

Recent earnings data shows fluctuating revenues and periods of negative EPS (Earnings Per Share). The negative EPS values are concerning and could be contributing to the recent stock underperformance and volatility.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue  | Profit Margin |
|--------------|----------|---------------|
| 2025-03-31   | $1.08B   | 14.51%        |
| 2024-12-31   | $1.23B   | 11.22%        |
| 2024-09-30   | $1.35B   | -7.68%        |
| 2024-06-30   | $1.43B   | -0.74%        |
| 2024-03-31   | $1.36B   | 2.86%         |

**Capital and Profitability:**

| Quarter      | Equity   | ROE      |
|--------------|----------|----------|
| 2025-03-31   | $10.03B  | 0.41%    |
| 2024-12-31   | $9.96B   | 0.76%    |
| 2024-09-30   | $10.24B  | -10.44%  |
| 2024-06-30   | $11.22B  | -1.68%   |
| 2024-03-31   | $11.53B  | 0.02%    |

**Analysis:**

*   **Revenue and Profitability:**  Revenue has generally been declining over the past year. The negative profit margins in two of the last five quarters are a significant concern.
*   **Capital and Profitability:**  Equity has also been declining, and the negative ROE (Return on Equity) values in two of the last five quarters further highlight profitability issues.

### 7. Overall Analysis

Albemarle Corp (ALB) is currently facing significant challenges. It has underperformed the S&P 500, shows a concerning trend of negative earnings and declining profitability, and experiences high volatility. While the MRI suggests low overall market risk and a short-term upward divergence trend exists, the high RSI indicates that the stock may be overbought in the short term.

The recent news highlights major developments, regulatory changes, and analysts' discussions, indicating the company is undergoing significant changes. The hybrid signal suggests a cautious approach to investing in Albemarle.

**Recommendation:**

Given the negative trends, high volatility, and overbought condition, a **cautious approach is warranted**. Investors should closely monitor company news, earnings reports, and analyst ratings before making any investment decisions. The extremely high "Expected Return" figure should be disregarded due to its implausibility. A further drop is not out of the question.
